MC-Val-Cit-PAB-OH | CAS 159857-80-4 - Request Quote
MC-Val-Cit-PAB-OH
| SZ CAT No: | SZ-D190002 |
| CAS No | 159857-80-4 |
| Mol.F. | C28H40N6O7 |
| Mol.Wt. | 572.7 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
MC-Val-Cit-PAB-OH is chemically 6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-((S)-1-(((S)-1-((4-(hydroxymethyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)hexanamide. MC-Val-Cit-PAB-OH is supplied with detailed characterization data compliant with regulatory guideline. MC-Val-Cit-PAB-OH can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dolastatin 10.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 159857-80-4
Purchase 159857-80-4
Order 159857-80-4
Enquire 159857-80-4
price of 159857-80-4
159857-80-4 Supplier
159857-80-4 Manufacturer
159857-80-4 Exporter
buy high quality MC-Val-Cit-PAB-OH
Purchase MC-Val-Cit-PAB-OH
MC-Val-Cit-PAB-OH suppliers
MC-Val-Cit-PAB-OH manufacturers
MC-Val-Cit-PAB-OH price
Order MC-Val-Cit-PAB-OH
Enquire MC-Val-Cit-PAB-OH
MC-Val-Cit-PAB-OH cost
MC-Val-Cit-PAB-OH Supplier
MC-Val-Cit-PAB-OH Distributor
MC-Val-Cit-PAB-OH for Method Validation
Dolastatin 10 Reference Standard
MC-Val-Cit-PAB-OH for ANDA Filing
MC-Val-Cit-PAB-OH for Forced Degradation Studies
MC-Val-Cit-PAB-OH Identification Standards
MC-Val-Cit-PAB-OH for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.